Talk to me about all things drug discovery, from small molecules to biologics to cell & gene therapies
Cambridge, England
Joined June 2016
- Tweets720
- Following365
- Followers445
- Likes2.2K
James Hallinan retweeted
Evotec SE announced today that Evotec has entered a technology development partnership with Novo Nordisk in cell therapy.
hubs.ly/Q02RbBGz0
#TogetherForMedicinesThatMatter #CellTherapy
James Hallinan retweeted
Join us at Booth #B20 at ELRIG Drug Discovery!
Don't miss Sven Schreiter's talk on "Automated High Content Screening", Oct 3rd, 12:15 PM.
And Saman Honarnejad will be co-chairing the "Advances in Assay Development and Screening" track.
More details: hubs.ly/Q02QBPM10
James Hallinan retweeted
Evotec at Advanced Therapies Europe (ATE)!
Our VP of ATMP Global Regulatory Affairs, Michela Gabaldo, will chair a panel on: Accelerating Cell and Gene Therapy Innovation: Regulatory Pathways in Europe.
Learn more: hubs.ly/Q02Nj1pp0
#ATE #Biotech #CellandGeneTherapy
James Hallinan retweeted
Join the Technology Networks online symposium, Advances in Drug Discovery & Development 2024 from 18 - 19 September 2024.
Our VP RNA Biology, Dr. Steffen Grimm, is presenting on "Drug Development in the RNA world"..
hubs.ly/Q02NhGB00
James Hallinan retweeted
We will delve into the latest advancements in microRNA research, exploring the therapeutic potential of #miRNA-targeting treatments, in our upcoming #oligonucleotide therapies webinar, "Unlocking the Potential of miRNA-Targeted Therapies".
Register here- hubs.ly/Q02Nn4xZ0
James Hallinan retweeted
Have you registered already?
This Wednesday, we are continuing our webinar series on hit identification strategies at Evotec.
Please register now for episode 4 "The Role of Structural Insights in Drug Discovery"
hubs.ly/Q02NhBKt0
James Hallinan retweeted
Evotec is supporting Advanced Therapies Europe #ATE24 as an Associate Sponsor, and our colleagues are representing our approach and our expertise to deliver iPSC-based cell therapeutics within various sessions. Learn more here- hubs.ly/Q02LRXJd0
#CellTherapy
James Hallinan retweeted
Evotec announced that the Company entered a partnership with Inserm, the French National Institute of Health and Medical Research, Lille University Hospital and Inserm Transfert (the private subsidiary of Inserm).
Learn more read the full press release- hubs.ly/Q02yXwF_0
James Hallinan retweeted
Watch @JustEvotecBio's first virtual roundtable on #continuousmanufacturing of #biologics. For this session we invited @Vir_Biotech as they discuss "How real is continuous manufacturing and what are the challenges?". Stream it now - hubs.ly/Q02h0jXc0
#researchneverstops
James Hallinan retweeted
Heartfelt thanks to BSTP for choosing Evotec Verona to host their annual meeting! It has been a pleasure to welcome these brilliant minds for scientific discussions about the future of cell therapy and the crucial role of pathology in this field #BSTPASM2023 #researchneverstops
James Hallinan retweeted
This month, join Evotec in Brussels at the European Society of Gene and Cell Therapy conference where our experts will present a scientific poster on AAV-based vectors. Meet the team at Booth #8 | Get in touch to book a meeting - hubs.ly/Q025BdSW0
#researchneverstops
James Hallinan retweeted
We're thrilled to announce our presence at #ELRIG2023 | Join us at Booth #B9 to explore the latest in drug discovery innovations. Schedule a meeting with our experts, Helen Box & James Hallinan - [email protected] #ELRIG2023 #DrugDiscovery #Innovation #researchneverstops
James Hallinan retweeted
Evotec is excited to participate in the iPSC-Derived Cell Therapies Summit in Boston this week. Our experts will present oral and scientific poster presentations | Discover more - hubs.ly/Q023Z2fd0 #researchneverstops #iPSC #celltherapy
James Hallinan retweeted
Join Evotec in Brussels next month at #ESGCT23 where our experts will present on AAV-based vectors | Meet the team at booth #8 to discuss your gene and cell therapy requirements | Get in touch to book a meeting - [email protected] #researchneverstops
So of all the exciting and innovative technology and product development consultancies in Cambridge, only one seems to have made the jump to... threads.net/t/CujAYiJIqFF/?i…
I had a great day earlier this week at the @BabrahamInst - have a look at my report: Data and what to do with it in advanced therapies linkedin.com/pulse/data-what… via @LinkedIn
It's #InternationalWomenInEngineeringDay - who are the women engineers that have inspired & impressed you? I'm lucky to have known @ELNSMNS and Mary Karavenglemann, both excellent biomedical engineers, and collaborated with @NeekaMashouf who is an amazing innovator @rubi_earth
A nice thing about living near @Cambridge_Uni is the range of seminars open to the public. Today's great presentation by Kelly Monk of @MonkLab1 at @VollumInstitute was on oligodendrocyte precursor cells, an exciting target for #genetherapy for #MultipleSclerosis @CentreMyelin
Have a great weekend everyone, and to kick it off check out my latest article: ISCT 2023 - cell therapy gets to the point linkedin.com/pulse/isct-2023… via @LinkedIn #GeneTherapy #celltherapy @ISCTglobal
I'm super excited by the news that about the @VerveTx / @EliLillyandCo deal for several reasons:
fiercebiotech.com/biotech/li… #GeneTherapy #synbio 1/3
1st - in vivo #GeneTherapy is very cool at the best of times, and using a targeted LNP vector is a nice approach. 2nd, the vector is aimed at the asialoglycoprotein receptor (ASGP-R) which was the receptor I used for my PhD! Back then you couldn't really express it so ... 2/3